Novel polymeric fluoropyrimidine CF10 demonstrates superior therapeutic index and survival advantage in patient-derived models of 5-fluorouracil-refractory colorectal cancer
Naresh Sah, Tasmin Rahman Omy, Subash Kairamkonda, Ganesh Acharya, Hithardha Palle, Pamela Luna, Chinnadurai Mani, William H. Gmeiner, Naga Koteswari Cheedella, Mark B. Reedy, Komaraiah Palle
This paper evaluates CF10, a novel polymeric fluoropyrimidine, showing superior antitumor activity and survival benefit in patient-derived colorectal cancer models compared to 5-FU.
bioRxiv · Apr 8, 2026 · PreprintCancer Biology